Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2808556rdf:typepubmed:Citationlld:pubmed
pubmed-article:2808556lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:2808556lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:2808556lifeskim:mentionsumls-concept:C0023884lld:lifeskim
pubmed-article:2808556lifeskim:mentionsumls-concept:C0450127lld:lifeskim
pubmed-article:2808556lifeskim:mentionsumls-concept:C0010592lld:lifeskim
pubmed-article:2808556lifeskim:mentionsumls-concept:C0035015lld:lifeskim
pubmed-article:2808556lifeskim:mentionsumls-concept:C0600688lld:lifeskim
pubmed-article:2808556lifeskim:mentionsumls-concept:C1882923lld:lifeskim
pubmed-article:2808556lifeskim:mentionsumls-concept:C1548437lld:lifeskim
pubmed-article:2808556lifeskim:mentionsumls-concept:C0522536lld:lifeskim
pubmed-article:2808556pubmed:issue8-9lld:pubmed
pubmed-article:2808556pubmed:dateCreated1989-11-28lld:pubmed
pubmed-article:2808556pubmed:abstractText52 orthotopic liver transplants were performed in DA to lewis rat strain combination, in order to appreciate cyclosporine toxicity, and efficacy at doses of 10 mg/kg day (G II) and 20 mg/kg/day (GIII) compared to liver allografts in DA/lewis rats. The first signs of cyclosporine hepatotoxicity are biological (increased plasma level of bilirubine and transaminase) that were noticed at the dose of 20 mg/kg/day. Histological signs (cells inclusion, hepatocytic necrosis) appeared late and were less constant as well as difficult to assert creatinine plasma level was the best reflect of cyclosporine nephrotoxicity. Renal toxicity was practically constant at the dose of 20 mg/kg/day. In spite of renal and hepatic toxicity, cyclosporin by itself, allows the abolition of the acute rejection of liver allografts in the rat.lld:pubmed
pubmed-article:2808556pubmed:languagefrelld:pubmed
pubmed-article:2808556pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2808556pubmed:citationSubsetIMlld:pubmed
pubmed-article:2808556pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2808556pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2808556pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2808556pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2808556pubmed:statusMEDLINElld:pubmed
pubmed-article:2808556pubmed:issn0021-7697lld:pubmed
pubmed-article:2808556pubmed:authorpubmed-author:CharpentierBBlld:pubmed
pubmed-article:2808556pubmed:authorpubmed-author:BismuthHHlld:pubmed
pubmed-article:2808556pubmed:authorpubmed-author:LokiecFFlld:pubmed
pubmed-article:2808556pubmed:authorpubmed-author:ReynesMMlld:pubmed
pubmed-article:2808556pubmed:authorpubmed-author:GigouMMlld:pubmed
pubmed-article:2808556pubmed:authorpubmed-author:GugenheimJJlld:pubmed
pubmed-article:2808556pubmed:authorpubmed-author:SettafAAlld:pubmed
pubmed-article:2808556pubmed:authorpubmed-author:LahlouM KMKlld:pubmed
pubmed-article:2808556pubmed:authorpubmed-author:Capron-Lauder...lld:pubmed
pubmed-article:2808556pubmed:issnTypePrintlld:pubmed
pubmed-article:2808556pubmed:volume126lld:pubmed
pubmed-article:2808556pubmed:ownerNLMlld:pubmed
pubmed-article:2808556pubmed:authorsCompleteYlld:pubmed
pubmed-article:2808556pubmed:pagination431-7lld:pubmed
pubmed-article:2808556pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:2808556pubmed:meshHeadingpubmed-meshheading:2808556-...lld:pubmed
pubmed-article:2808556pubmed:meshHeadingpubmed-meshheading:2808556-...lld:pubmed
pubmed-article:2808556pubmed:meshHeadingpubmed-meshheading:2808556-...lld:pubmed
pubmed-article:2808556pubmed:meshHeadingpubmed-meshheading:2808556-...lld:pubmed
pubmed-article:2808556pubmed:meshHeadingpubmed-meshheading:2808556-...lld:pubmed
pubmed-article:2808556pubmed:meshHeadingpubmed-meshheading:2808556-...lld:pubmed
pubmed-article:2808556pubmed:meshHeadingpubmed-meshheading:2808556-...lld:pubmed
pubmed-article:2808556pubmed:meshHeadingpubmed-meshheading:2808556-...lld:pubmed
pubmed-article:2808556pubmed:meshHeadingpubmed-meshheading:2808556-...lld:pubmed
pubmed-article:2808556pubmed:meshHeadingpubmed-meshheading:2808556-...lld:pubmed
pubmed-article:2808556pubmed:meshHeadingpubmed-meshheading:2808556-...lld:pubmed
pubmed-article:2808556pubmed:meshHeadingpubmed-meshheading:2808556-...lld:pubmed
pubmed-article:2808556pubmed:meshHeadingpubmed-meshheading:2808556-...lld:pubmed
pubmed-article:2808556pubmed:articleTitle[Cyclosporin, toxicity and efficacy in rejection of liver allografts in the rat].lld:pubmed
pubmed-article:2808556pubmed:affiliationGroupe de Recherche de Chirurgie Hépatique, Hôpital Paul Brousse, Villejuif.lld:pubmed
pubmed-article:2808556pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2808556pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:2808556pubmed:publicationTypeEnglish Abstractlld:pubmed